Ovid Therapeutics, Inc. (OVID)
2.375
-0.10
(-3.85%)
USD |
NASDAQ |
Oct 22, 16:00
2.375
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Market Cap : 438.79M for Oct. 22, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 21, 2026 | 456.35M |
| October 20, 2026 | 436.02M |
| October 19, 2026 | 400.92M |
| October 16, 2026 | 397.22M |
| October 15, 2026 | 417.55M |
| October 14, 2026 | 404.62M |
| October 13, 2026 | 404.62M |
| October 12, 2026 | 445.26M |
| October 09, 2026 | 454.50M |
| October 08, 2026 | 432.33M |
| October 07, 2026 | 436.02M |
| October 06, 2026 | 437.87M |
| October 05, 2026 | 432.33M |
| October 02, 2026 | 439.72M |
| October 01, 2026 | 448.96M |
| September 30, 2026 | 460.04M |
| September 29, 2026 | 469.28M |
| September 28, 2026 | 454.50M |
| September 25, 2026 | 443.41M |
| September 24, 2026 | 460.97M |
| September 23, 2026 | 474.82M |
| September 22, 2026 | 509.93M |
| September 21, 2026 | 500.69M |
| September 18, 2026 | 496.99M |
| September 17, 2026 | 498.84M |
| Date | Value |
|---|---|
| September 16, 2026 | 495.15M |
| September 15, 2026 | 500.69M |
| September 14, 2026 | 506.23M |
| September 11, 2026 | 496.99M |
| September 10, 2026 | 485.91M |
| September 09, 2026 | 498.84M |
| September 08, 2026 | 508.08M |
| September 04, 2026 | 517.32M |
| September 03, 2026 | 513.62M |
| September 02, 2026 | 500.69M |
| September 01, 2026 | 509.93M |
| August 31, 2026 | 493.30M |
| August 28, 2026 | 517.32M |
| August 27, 2026 | 541.33M |
| August 26, 2026 | 532.10M |
| August 25, 2026 | 537.64M |
| August 24, 2026 | 521.01M |
| August 21, 2026 | 517.32M |
| August 20, 2026 | 506.23M |
| August 19, 2026 | 541.33M |
| August 18, 2026 | 524.71M |
| August 17, 2026 | 533.94M |
| August 14, 2026 | 522.86M |
| August 13, 2026 | 517.32M |
| August 12, 2026 | 484.06M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.495B |
| Alnylam Pharmaceuticals, Inc. | 30.40B |
| Anika Therapeutics, Inc. | 281.24M |
| Savara, Inc. | 932.51M |
| Vericel Corp. | 2.199B |
Market Cap Related Metrics
| PS Ratio | 182.44 |
| Price to Book Value | 2.091 |
| Price | 2.375 |
| Earnings Yield | -10.67% |